Protecting and improving the health of communities through promotion of healthy lifestyles, research, and detection and control of infectious diseases.
This briefing will explore how the U.S. has fared during the COVID-19 pandemic to-date and highlight key takeaways learned in the U.S. response, as well as important lessons learned from peer countries.
In this briefing, experts will discuss how flu and the COVID-19 pandemic have intersected over the past 18 months and why we should also prioritize flu preparedness policy. Panelists will also highlight available federal policy levers and discuss policy strategies to improve our flu response.
This event outlined the latest science on nicotine initiation, addiction, and cessation, the use of flavorings in tobacco products, as well as the disparate impact of menthol tobacco products on various populations, especially communities of color.
This briefing reviewed the opportunities and challenges that have arisen for first line providers and current integration efforts to ensure equitable preventative care for the American public. Experts addressed the role of data sharing, payment systems, and workforce provisions.
There is no excerpt because this is a protected post.
Expert panelists delved into where America stands in public health a year into the COVID-19 pandemic. They discussed how the COVID-19 pandemic has shaped clinical care, state preparedness, and the individual consumer experience and shed light on promising frameworks and infrastructures being built today to protect Americans from a major public health emergency tomorrow.
Attendees learned the challenges and opportunities states face in safe and timely vaccine deployment and supply management, plans states are executing to ensure equitable vaccine distribution, and plans states are executing to ensure equitable vaccine distribution along the way.
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
This briefing provided an overview of how census data is collected, analyzed, and utilized, with a particular focus on how this process impacts health policy and public health.
During this webinar, panelists addressed the following learning goals: the short- and long-term impact of COVID-19 on mental health and well being; evidence-based interventions and promising technology to reach people where they are and improve outcomes; and sustainable solutions to address the mental health impact of COVID-19 and advance access to behavioral health services beyond the pandemic.
COVID-19 Webinar Series Session 18 – Health Inequities: Addressing the Disease Burden in Black, Indigenous, and People of Color Communities
During this webinar, speakers examined the following learning goals: the disproportionate impact of COVID-19 on Black, Indigenous, and People of Color communities in the U.S.; the drivers of these disparities; and short- and long-term policy options to advance equity and improve COVID-19 outcomes.
This webinar will explain the role of Medicaid in the COVID-19 pandemic. Panelists will discuss financing challenges of the Medicaid program—the nation’s health care safety net—as more people become eligible for Medicaid coverage and demand for health services shifts.
During this webinar, panelists discussed the recent evolution of our primary care system and outlined policy levers to bolster our nation’s primary care infrastructure.
During this webinar, panelists explored the impact of the pandemic on different facets of the drug supply chain and discussed policy options to strengthen the system.
COVID-19 Webinar Series Session 14 – Lessons from Home and Abroad: Implementing a Contact Tracing Strategy
During this webinar, panelists discussed case studies from abroad and best practices as policymakers look to implement a contact tracing strategy in the United States.
During this webinar, panelists discussed policy options to support high quality care for nursing home residents during the COVID-19 pandemic.
COVID-19 Webinar Series Session 12 – From Data to Decisions: Mobilizing a Surveillance Infrastructure
During this webinar, panelists will explore options policymakers can pursue to strengthen our surveillance infrastructure as we move from mitigation to containment of the COVID-19 pandemic.
In this webinar, panelists will discuss the unique challenges that face rural health systems and the strategies they are employing during the emergency response. They will also highlight current or future legislative and administrative policy solutions.
During this webinar, experts discussed steps necessary to bring vaccines from the lab to the front lines.
During this webinar, panelists discussed the consequences of social isolation, as well as potential interventions that government leaders, providers, and communities can implement.
During this pre-recorded interview, we spoke with Dr. Richard A. Stone, the VHA’s Executive in Charge. He explained the coronavirus response efforts underway at the Department of Veterans Affairs to meet the needs of veterans and fulfill the department’s “Fourth Mission” to support other health systems responding to this crisis.
With mandated lockdowns and social distancing guidelines in effect throughout the country, policymakers and public health professionals aim to identify other effective approaches to contain the spread of COVID-19. During this teleconference, experts will discuss the prescription drug supply chain, the progression of a COVID-19 vaccine, and the related infrastructure needs.
COVID-19 Webinar Series Session 8 – Advancing Prevention and Treatment: A Conversation with Dr. Mark McClellan
During this webinar, Dr. Mark McClellan, former FDA Commissioner and current director of the Duke-Margolis Center for Health Policy, offered strategies to expedite the development and evaluation of medical products to track, treat, and prevent the novel coronavirus.
As the coronavirus spreads, health systems across the country are gearing up for an influx of patients. States play a central role in the organization of health care and public health infrastructure, but a range of resources and legislative decisions, as well as different demographics, can lead to divergent outcomes across states.
The rapid spread of the novel coronavirus has led to a growing number of COVID-19 hospitalizations and concerns about health system capacity. Models and projections can be useful tools to help policymakers at the state and local levels make evidence-based decisions to slow the spread of the virus and bolster health system capacity. During this webinar, panelists highlighted the role of modeling in helping states prepare and respond to COVID-19.
During this pre-recorded interview, we spoke with Dr. Rebecca Katz, who explored how decision-makers can use these tools to weigh policy tradeoffs. She discussed the range of existing models, as well as the key inputs and assumptions that drive projections.
This week, Congress is set to pass the third major legislative package in response to the COVID-19 outbreak. This webinar offered a high-level analysis of the policies that Congress and the administration have pursued to date and what we can expect in the coming months.
During this webinar, Michael J. Alkire, the president of Premier—the largest global health care supply chain in the U.S.—provided a frontline perspective on the state of the medical supply chain.
As the coronavirus spreads, health care systems across the country are gearing up for an influx of patients. But how do we ensure that we’re protecting the health of the health care workers on the front lines of the outbreak?
This webinar explored challenges to protect health care workers at the frontline of the COVID-19 response. Our panelists highlighted innovative approaches to bolster health system capacity and protect providers, such as increasing the availability of telemedicine.
COVID-19 Webinar Series Session 3 – Leading through Crisis: Perspectives from Gov. Michael O. Leavitt
Michael O. Leavitt, former Governor of Utah and former Secretary of the United States Department of Health and Human Services, explored the levers available to policymakers at the local, state, and federal levels as they respond to the novel coronavirus.
This webinar provided insight into the experience of health officials at the front lines of the COVID-19 response and explored steps policymakers can take to support these entities.
During this webinar, Dr. Kathleen Winter, an assistant professor at the University of Kentucky College of Public Health, explained the epidemiology of the novel coronavirus and discussed evidence-based practices to slow the transmission.